DE602005020048D1 - Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption - Google Patents

Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption

Info

Publication number
DE602005020048D1
DE602005020048D1 DE602005020048T DE602005020048T DE602005020048D1 DE 602005020048 D1 DE602005020048 D1 DE 602005020048D1 DE 602005020048 T DE602005020048 T DE 602005020048T DE 602005020048 T DE602005020048 T DE 602005020048T DE 602005020048 D1 DE602005020048 D1 DE 602005020048D1
Authority
DE
Germany
Prior art keywords
acetaminophes
aspirine
caffeine
alkaline
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005020048T
Other languages
German (de)
English (en)
Inventor
Rong Liu
Michael Corbo
Jatin Desai
Gerard P Frunzi
Xiaohong Qi
Candice Y Choi
Rahul R Gandhi
Atef Z Boulos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of DE602005020048D1 publication Critical patent/DE602005020048D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE602005020048T 2004-10-28 2005-10-26 Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption Expired - Lifetime DE602005020048D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62281204P 2004-10-28 2004-10-28
PCT/US2005/038507 WO2006049978A1 (en) 2004-10-28 2005-10-26 Composition comprising acetaminophen, caffeine and optionally aspirin together with an alkiline agent fr enhanced absorption

Publications (1)

Publication Number Publication Date
DE602005020048D1 true DE602005020048D1 (de) 2010-04-29

Family

ID=35744599

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005020048T Expired - Lifetime DE602005020048D1 (de) 2004-10-28 2005-10-26 Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption

Country Status (17)

Country Link
US (1) US20070298096A1 (cg-RX-API-DMAC7.html)
EP (1) EP1807068B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008518914A (cg-RX-API-DMAC7.html)
CN (1) CN101048155A (cg-RX-API-DMAC7.html)
AR (1) AR051145A1 (cg-RX-API-DMAC7.html)
AT (1) ATE460930T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005302618B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0520000A2 (cg-RX-API-DMAC7.html)
CA (1) CA2583517C (cg-RX-API-DMAC7.html)
DE (1) DE602005020048D1 (cg-RX-API-DMAC7.html)
MX (1) MX2007005121A (cg-RX-API-DMAC7.html)
NO (1) NO20072255L (cg-RX-API-DMAC7.html)
PE (1) PE20061125A1 (cg-RX-API-DMAC7.html)
PL (1) PL1807068T3 (cg-RX-API-DMAC7.html)
PT (1) PT1807068E (cg-RX-API-DMAC7.html)
RU (1) RU2398571C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006049978A1 (cg-RX-API-DMAC7.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0607085D0 (en) 2006-04-07 2006-05-17 Smithkline Beecham Corp Novel compositions
CN100417385C (zh) * 2006-09-26 2008-09-10 林星 一种用于治疗外伤的外用制剂
GB0707489D0 (en) * 2007-04-18 2007-05-23 Renaissance Pharma Compounds
CN101596163B (zh) * 2008-06-06 2012-06-27 康美保宁(四川)制药有限公司 阿咖酚微丸制剂及其制备方法
GB0813929D0 (en) * 2008-07-30 2008-09-03 Glaxo Group Ltd Novel method
CN102861040B (zh) * 2012-08-02 2014-04-23 广东环球制药有限公司 含有阿司匹林、对乙酰氨基酚和咖啡因的药物组合物及其制备方法
CN102949401A (zh) * 2012-09-06 2013-03-06 广东九明制药有限公司 对乙酰氨基酚、乙酰水杨酸和咖啡因组合物及其制备工艺
US10124005B1 (en) * 2017-12-15 2018-11-13 Lisa Josette Myslinski Multisymptom migraine combination medication
CN110711197B (zh) * 2018-07-12 2023-11-24 北京恒润泰生医药科技有限公司 阿司匹林和对乙酰氨基酚的分子复合物加咖啡因,其制备,活性及应用
CN108853124A (zh) * 2018-08-15 2018-11-23 康美保宁(四川)制药有限公司 一种阿咖酚制剂及其制剂方法
GB202007670D0 (en) * 2020-05-22 2020-07-08 Glaxosmithkline Consumer Healthcare Holdings Us Llc Pharmaceutical composition

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4294819A (en) * 1980-08-18 1981-10-13 Bristol-Myers Company Alkaline analgesic capsule
CA1182049A (en) * 1981-07-13 1985-02-05 Francis J. Sterbenz Apap antacid composition
US5296241A (en) * 1991-04-03 1994-03-22 Brimberg Barnett J Therapeutic composition and method of using same for treatment of hangover
JP3122748B2 (ja) * 1991-11-29 2001-01-09 ライオン株式会社 イブプロフェン含有解熱鎮痛剤
JP3172749B2 (ja) * 1992-02-17 2001-06-04 ライオン株式会社 イブプロフェン含有製剤
JPH06227995A (ja) * 1993-02-03 1994-08-16 Takeda Chem Ind Ltd 安定化された固型製剤
JPH07206689A (ja) * 1994-01-21 1995-08-08 Barnett Lab Ltd 治療組成物および宿酔の治療のためのこの組成物の使用法
DE19502789A1 (de) * 1995-01-28 1996-08-01 Dirk Krischenowski Arzneimittel
RU2101014C1 (ru) * 1995-09-07 1998-01-10 Акционерное общество "Курский комбинат лекарственных средств" Анальгезирующее, противовоспалительное, жаропонижающее лекарственное средство и способ его получения
GB9704524D0 (en) * 1997-03-05 1997-04-23 Smithkline Beecham Plc Composition
US5972916A (en) * 1997-07-14 1999-10-26 Bristol-Myers Squibb Company Compositions containing the nonprescription combination of acetaminophen, aspirin and caffeine to alleviate the pain and symptoms of migraine
JP2002012557A (ja) * 2000-06-28 2002-01-15 Lion Corp 内服薬組成物
US20040147606A1 (en) * 2001-05-25 2004-07-29 Yoichi Onuki Medicinal compositions
JP4553552B2 (ja) * 2003-01-08 2010-09-29 日東薬品工業株式会社 生体リズム応用キット

Also Published As

Publication number Publication date
AR051145A1 (es) 2006-12-20
PT1807068E (pt) 2010-04-19
US20070298096A1 (en) 2007-12-27
EP1807068B1 (en) 2010-03-17
BRPI0520000A2 (pt) 2009-04-07
PE20061125A1 (es) 2006-11-08
AU2005302618A1 (en) 2006-05-11
RU2007119641A (ru) 2008-12-10
RU2398571C2 (ru) 2010-09-10
EP1807068A1 (en) 2007-07-18
ATE460930T1 (de) 2010-04-15
WO2006049978A1 (en) 2006-05-11
MX2007005121A (es) 2007-06-22
CA2583517A1 (en) 2006-05-11
AU2005302618B2 (en) 2009-10-22
CA2583517C (en) 2013-06-04
CN101048155A (zh) 2007-10-03
PL1807068T3 (pl) 2010-08-31
JP2008518914A (ja) 2008-06-05
NO20072255L (no) 2007-07-18

Similar Documents

Publication Publication Date Title
HUS2500037I1 (hu) Javított protofibril szelektív antitestek és alkalmazásuk
LTC1763368I2 (lt) Deriniai, apimantys antimuskarininius agentus ir beta-adrenerginius agonistus
IL184324A0 (en) Pyy agonists and uses thereof
BRPI0722081A2 (pt) Complexo metálico, composto polimérico e dispositivo contendo os mesmos
DE602005025460D1 (de) Teilchenförmiges wasserabsorptionsmittel mit unregelmässiger pulverform
EP1795456A4 (en) CAPSUED CONTAINER
HUE052428T2 (hu) Készítmény és eljárás acetaldehid gyomorban való megkötésére
EP1927603A4 (en) COMPOSITION OF SYRUP, RESIN MORTAR COMPOSITION AND METHOD OF APPLICATION
ATE460930T1 (de) Zusammensetzung mit acetaminophen, koffein und aspirin zusammen mit einem alkaliwirkstoff für verbesserte absorption
ATE419193T1 (de) Verschlusskappe
GB0524501D0 (en) Line-marking device with rotatable laser
EP1790336A4 (en) CAPSULE FILM COMPOSITION, CAPSULE FILM, AND CAPSULE COMPRISED THEREFROM
DE602005009988D1 (de) Härtbare Zusammensetzung und deren Verwendung
PT1954669E (pt) Feniletilaminas substituídas com actividade serotoninérgica e/ou norepinefrinérgica
PL1926477T3 (pl) Kompozycja zawierająca NLPZ oraz paracetamol
IL176408A (en) Electrochemical nitrate destruction
TWI367091B (en) Sedative effect-enabling agent and sedative aroma composition comprising the same
EP1816169A4 (en) FLAMMWIDIRGE RESIN COMPOSITION, MANUFACTURING METHOD AND METAL METHOD THEREFOR
ITGE20050032A1 (it) Procedimento e dispositivo per spargere trucioli.
EP1961771A4 (en) BISMUTH HYALURONATE, PREPARATION METHOD AND USE THEREOF
IL186851A0 (en) Styrylsulfonamides, their manufacture and use as pharmaceutical agents
ES1056426Y (es) Tapon con cañita incorporada.
EP1722013A4 (en) GALVANIZATION IN THE PRESENCE OF CO2
ES1059592Y (es) Contenedor para recogida de latas y pilas.
FI20055112A0 (fi) Hirsiaihio sekä menetelmä sen valmistamiseksi ja käyttämiseksi

Legal Events

Date Code Title Description
8364 No opposition during term of opposition